false
0001526119
0001526119
2026-11-17
2026-11-17
iso4217:USD
xbrli:shares
iso4217:USD
xbrli:shares
UNITED STATES
SECURITIES AND EXCHANGE COMMISSION
WASHINGTON, D.C. 20549
FORM 8-K
CURRENT REPORT
Pursuant to Section 13 or 15(d) of the
Securities Exchange Act of 1934
Date of report (Date of earliest event reported):
November 17, 2026
Verastem,
Inc.
(Exact Name of Registrant as Specified in
Charter)
| Delaware |
|
001-35403 |
|
27-3269467 |
(State or Other Jurisdiction
of Incorporation) |
|
(Commission File Number) |
|
(IRS Employer Identification No.) |
| 117 Kendrick Street, Suite 500, Needham, MA |
|
02494 |
| (Address of Principal Executive Offices) |
|
(Zip Code) |
Registrant’s telephone number, including
area code: (781) 292-4200
(Former Name or Former Address, if Changed
Since Last Report)
Check the appropriate box below if the Form 8-K filing is intended
to simultaneously satisfy the filing obligation of the registrant under any of the following provisions:
| ¨ | Written communications pursuant to Rule 425 under
the Securities Act (17 CFR 230.425) |
| ¨ | Soliciting material pursuant to Rule 14a-12 under
the Exchange Act (17 CFR 240.14a-12) |
| ¨ | Pre-commencement communications pursuant to Rule 14d-2(b) under
the Exchange Act (17 CFR 240.14d-2(b)) |
| ¨ | Pre-commencement communications pursuant to Rule 13e-4(c) under
the Exchange Act (17 CFR 240.13e-4(c)) |
Securities registered pursuant to Section 12(b)
of the Act:
| Title of each class |
|
Trading Symbol(s) |
|
Name
of each exchange on which registered |
| Common stock, $0.0001 par value per share |
|
VSTM |
|
The Nasdaq Capital Market |
Indicate by check mark whether the registrant is an emerging
growth company as defined in Rule 405 of the Securities Act of 1933 (§230.405 of this chapter) or Rule 12b-2 of the Securities
Exchange Act of 1934 (§240.12b-2 of this chapter).
Emerging
growth company ¨
If
an emerging growth company, indicate by check mark if the registrant has elected not to use the extended transition period for
complying with any new or revised financial accounting standards provided pursuant to Section 13(a) of the Exchange Act. ¨
Item 5.02. Departure of Directors or Certain Officers; Election
of Directors; Appointment of Certain Officers; Compensatory Arrangements of Certain Officers
Chief Executive Officer Succession
As previously disclosed on October 14, 2026, Daniel
W. Paterson notified the Board of Directors (the “Board”) of Verastem, Inc. (the “Company”) of his decision to
retire as President and Chief Executive Officer of the Company, effective January 1, 2027 (the “Effective Date”). In connection
with the retirement of Mr. Paterson, Michael Bailey was appointed to the position of President and Chief Executive Officer, effective
as of the Effective Date (the “CEO Succession”).
Bailey Consulting Agreement
In connection with the CEO Succession described
above, the Company and Mr. Bailey entered into a consulting and advisory agreement, dated November 17, 2026, and effective November 1,
2026 (the “Bailey Consulting Agreement”), pursuant to which Mr. Bailey will provide advisory services and assist the Company
with the CEO Succession until December 31, 2026, unless the Bailey Consulting Agreement is earlier terminated by either party upon 30
days’ advance written notice.
In exchange for providing such services, Mr. Bailey
will receive a monthly consulting fee of $40,000, prorated for any month of partial service and payable in cash, equity or equity-based
awards, as determined by the Board. The Bailey Consulting Agreement contains certain covenants and agreements of the parties, including
a perpetual confidentiality obligation.
The foregoing summary is qualified in its entirety
by reference to the Bailey Consulting Agreement, which is filed as Exhibit 10.1 to this Current Report on Form 8-K and is incorporated
in this Item 5.02 by reference.
Item 9.01. Financial Statements and Exhibits
| Exhibit No. |
|
Description |
| 10.1 |
|
Consulting and Advisory Agreement dated November 17, 2026, by and between Verastem, Inc. and Michael Bailey |
| 104 |
|
Cover Page Interactive Data File (embedded within the Inline XBRL document) |
SIGNATURES
Pursuant to the requirements of the Securities
Exchange Act of 1934, the registrant has duly caused this report to be signed on its behalf by the undersigned hereunto duly authorized.
| |
VERASTEM, INC. |
| |
|
|
| Dated: November 19, 2026 |
By: |
/s/ Daniel W. Paterson |
| |
|
Daniel W. Paterson |
| |
|
President and Chief Executive Officer |